Remove 2027 Remove M&A Remove Valuation
article thumbnail

Oncology dealmaking fuels biotech M&A

JD Supra: Mergers

Global spending on cancer medicines is set to reach US$375 billion by 2027, with innovation in drug discovery and development ramping up to meet rising demand. While the global biotech sector continues to grapple with elevated interest rates and plunging valuations, the oncology sector continues to attract dealmaker interest.

M&A 182
article thumbnail

Food and Beverage Industry: Dairy Sector Spotlight

Focus Investment Banking

CAGR through 2027. Who Are The Buyers in Dairy Products M&A? Earlier reports indicated 15 billion euros as a ballpark valuation of the ice cream business. Health trends, dietary preferences, and sustainability concerns are key drivers influencing these changes. over the next three years, according to Euromonitor.

Food 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 10 Benefits Software Modernization for SaaS Growth or Acquisition

Software Equity Group

trillion by 2027. As such, it enhances your potential to realize your exit strategy and achieve an attractive valuation in the M&A market. #1. Software companies must evolve from the inside out to stay relevant, focusing on quality teams, code, processes, and more—beyond just the latest technology. More on this later.)

article thumbnail

Cooley’s 2023 Cross-Border M&A Year in Review: Navigating Choppy Waters into a More Buoyant 2024

Cooley M&A

Cross-border M&A activity in 2023 was impacted by heightened geopolitical conflicts, high inflation and interest rates, and increased regulatory pressures as the global economy remained clouded by looming recession fears. The aggressive rate hikes contributed to the decline in M&A activity in 2023. trillion and $4.09

M&A 52